Trexquant Investment’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.01M | Buy |
559,184
+169,792
| +44% | +$1.52M | 0.06% | 526 |
|
|
2025
Q1 | $2.92M | Sell |
389,392
-104,964
| -21% | -$787K | 0.03% | 727 |
|
|
2024
Q4 | $3.72M | Sell |
494,356
-386,635
| -44% | -$2.91M | 0.04% | 631 |
|
|
2024
Q3 | $6.7M | Sell |
880,991
-156,180
| -15% | -$1.19M | 0.08% | 358 |
|
|
2024
Q2 | $6.41M | Buy |
1,037,171
+920,238
| +787% | +$5.69M | 0.1% | 328 |
|
|
2024
Q1 | $594K | Sell |
116,933
-304,583
| -72% | -$1.55M | 0.01% | 1099 |
|
|
2023
Q4 | $2.52M | Sell |
421,516
-171,096
| -29% | -$1.02M | 0.06% | 476 |
|
|
2023
Q3 | $4.2M | Buy |
592,612
+257,094
| +77% | +$1.82M | 0.11% | 270 |
|
|
2023
Q2 | $2.36M | Buy |
335,518
+219,148
| +188% | +$1.54M | 0.06% | 444 |
|
|
2023
Q1 | $971K | Sell |
116,370
-99,890
| -46% | -$833K | 0.03% | 742 |
|
|
2022
Q4 | $2.48M | Buy |
216,260
+109,790
| +103% | +$1.26M | 0.07% | 357 |
|
|
2022
Q3 | $1.34M | Buy |
106,470
+32,958
| +45% | +$415K | 0.05% | 449 |
|
|
2022
Q2 | $778K | Buy |
73,512
+13,359
| +22% | +$141K | 0.03% | 624 |
|
|
2022
Q1 | $978K | Buy |
+60,153
| New | +$978K | 0.05% | 481 |
|
|
2021
Q4 | – | Sell |
-12,632
| Closed | -$182K | – | 1295 |
|
|
2021
Q3 | $182K | Sell |
12,632
-7,451
| -37% | -$107K | 0.01% | 977 |
|
|
2021
Q2 | $318K | Buy |
+20,083
| New | +$318K | 0.03% | 684 |
|
|
2017
Q3 | – | Sell |
-38,432
| Closed | -$214K | – | 770 |
|
|
2017
Q2 | $214K | Sell |
38,432
-12,359
| -24% | -$68.8K | 0.06% | 635 |
|
|
2017
Q1 | $427K | Buy |
50,791
+14,333
| +39% | +$120K | 0.05% | 602 |
|
|
2016
Q4 | $231K | Buy |
+36,458
| New | +$231K | 0.04% | 758 |
|
|
2015
Q4 | – | Sell |
-55,279
| Closed | -$630K | – | 1009 |
|
|
2015
Q3 | $630K | Sell |
55,279
-71,021
| -56% | -$809K | 0.05% | 631 |
|
|
2015
Q2 | $1.89M | Buy |
126,300
+103,600
| +456% | +$1.55M | 0.21% | 105 |
|
|
2015
Q1 | $204K | Buy |
+22,700
| New | +$204K | 0.02% | 928 |
|